<unk>  was formerly approved and marketed as a form of androgen replacement therapy for the treatment of hypogonadism in men, but has since been discontinued and withdrawn in most countries, including in the United States. It was given at a dosage of 5 to 10 mg/day in men and 2.5 mg/day in women. Available forms<unk>  was provided in the form of 2.5 and 5 mg oral tablets.
Metandienone
Amrinone
Nortilidine
Iofetamine 
Boldenone undecylenate
Colestilan
Verapamil
Amiodarone